Eric Vivier va combattre le cancer chez Innate Pharma
January 24, 2018Article from les Echos.
Access to the article (in French)
Podium "face aux dirigeants" d'Actionaria 2017 - Interview de Mondher Mahjoubi
November 29, 2017Conference call: update on lirilumab program
November 22, 2017BFM Business - Check-Up Santé L'entretien: Innate Pharma poursuit son évolution vers une société biopharmaceutique intégrée
September 30, 2017Conference call replay (september 18th 2017): Half-year results
September 20, 2017Conference call on acquisition of the anti-C5aR antibody (IPH5401) and IPH4102 data (presented at ICML on June 14, 2017) | June 15, 2017
June 15, 2017Delivering next generation of immuno-oncology therapies in managing cancer
March 22, 2017By Pierre DODION Executive Vice President and Chief Medical Officer, Innate Pharma & Hatem A. AZIM Medical Director Clinical Development, Innate Pharma
Conference call replay (March 7th, 2017): 2016 financial statements
March 8, 2017Conference call replay (February 6th, 2017), Innate Pharma announces top-line results from EffiKIR trial
February 6, 2017Innate Pharma débauche le stratège « cancérologie » d’AstraZeneca
December 19, 2016La biotech française spécialisée dans l’immunothérapie des cancers se dote d’un nouveau dirigeant, plus en phase avec son degré de maturité.
